Ország: Egyesült Államok
Nyelv: angol
Forrás: NLM (National Library of Medicine)
Sotalol hydrochloride (UNII: HEC37C70XX) (Sotalol - UNII:A6D97U294I)
Mylan Institutional LLC
Sotalol hydrochloride
Sotalol hydrochloride 15 mg in 1 mL
PRESCRIPTION DRUG
New Drug Application
SOTALOL HYDROCHLORIDE- SOTALOL HYDROCHLORIDE INJECTION MYLAN INSTITUTIONAL LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE SOTALOL HYDROCHLORIDE INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR SOTALOL HYDROCHLORIDE INJECTION. SOTALOL HYDROCHLORIDE INJECTION FOR INTRAVENOUS USE INITIAL U.S. APPROVAL: 1992 WARNING: LIFE THREATENING PROARRHYTHMIA _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING_. • • • • INDICATIONS AND USAGE Sotalol hydrochloride for intravenous use is an antiarrhythmic agent indicated for: • Oral sotalol is indicated for: • • DOSAGE AND ADMINISTRATION Intravenous sotalol must be diluted. Appropriate diluents are saline, 5% dextrose in water (D5W), or Ringer's lactate. Intravenous sotalol is administered by a volumetric infusion pump over 5 hours at a constant infusion rate. See full prescribing information for general rules and safety measures (2.1), dose selection (2.2) and preparation of infusion (2.3) MAINTENANCE OF SOTALOL THERAPY – REPLACEMENT OF ORAL DOSING The intravenous dose is approximately equal to the oral dose and administered at the same dosing frequency. 75 mg of intravenous sotalol is approximately equal to 80 mg of oral sotalol (2.2) INITIATION OF THERAPY • • • DOSAGE FORMS AND STRENGTHS • CONTRAINDICATIONS • • • • • SOTALOL CAN CAUSE LIFE THREATENING VENTRICULAR TACHYCARDIA ASSOCIATED WITH QT INTERVAL PROLONGATION. DO NOT INITIATE SOTALOL THERAPY IF THE BASELINE QTC IS LONGER THAN 450 MS. IF THE QT INTERVAL PROLONGS TO 500 MS OR GREATER, THE DOSE MUST BE REDUCED, THE DURATION OF THE INFUSION PROLONGED OR THE DRUG DISC O NTINUE D. PATIENT SHOULD BE HOSPITALIZED IN A FACILITY THAT CAN PROVIDE CARDIAC RESUSCITATION AND CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING. ADJUST THE DOSING INTERVAL BASED ON CREATININE CLEARANCE. Substitution for oral sotalol in patients who are unable to take sotalol orally (1.1) Maintenance of normal sinus rhythm in pati Olvassa el a teljes dokumentumot